Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Opus Genetics (IRD) Shares Issued (2020 - 2026)

Opus Genetics has reported Shares Issued over the past 11 years, most recently at $738000.0 for Q1 2026.

  • Quarterly Shares Issued rose 14660.0% to $738000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Mar 2026, up 261.29% year-over-year, with the annual reading at $820000.0 for FY2025, N/A changed from the prior year.
  • Shares Issued was $738000.0 for Q1 2026 at Opus Genetics, down from $793000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $4.4 million in Q4 2022 and troughed at -$5.5 million in Q4 2023.
  • The 5-year median for Shares Issued is $765500.0 (2025), against an average of $832083.3.
  • Year-over-year, Shares Issued soared 440000.0% in 2022 and then plummeted 223.88% in 2023.
  • A 5-year view of Shares Issued shows it stood at $4.4 million in 2022, then plummeted by 223.88% to -$5.5 million in 2023, then surged by 109.17% to $500000.0 in 2024, then skyrocketed by 58.6% to $793000.0 in 2025, then fell by 6.94% to $738000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Shares Issued are $738000.0 (Q1 2026), $793000.0 (Q4 2025), and $1.7 million (Q3 2025).